Italia në alarm, 4-vjeçarja vdes nga malaria, u infektua në spital

epa04858235 (FILE) A file picture dated 23 April 2008 shows an 'Anopheles gambiae' mosquito, a vector for the malaria parasite, drawing blood while biting a researcher at the International Centre for Insect Physiology and Ecology (ICIPE) insect research facility in Nairobi, Kenya. According to media reports British multinational pharmaceutical company GlaxoSmithKline (GSK), announced on 25 July 2015 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities. EPA/STEPHEN MORRISON